The Non-competitive Antagonists 2-Methyl-6-(phenylethynyl)pyridine and 7-Hydroxyiminocyclopropan[b]chromen-1a-carboxylic Acid Ethyl Ester Interact with Overlapping Binding Pockets in the Transmembrane Region of Group I Metabotropic Glutamate Receptors*
暂无分享,去创建一个
F. Gasparini | L. Prézeau | I. Vranesic | J. Pin | S. Litschig | P. Flor | R. Kuhn | A. Pagano | N. Stoehr | M. Heinrich | P. Floersheim | D. Rüegg | C. Stierlin | F. Carroll | A. Cambria | L. Prézeau
[1] M. Al-Moslih,et al. The kinetics of DEAE-dextran-induced cell sensitization to transfection. , 1973, The Journal of general virology.
[2] J. Dubuisson,et al. Proteins of bovine herpesvirus type 4 released into the culture medium of productively infected cells: identification of a 135K glycoprotein involved in viral attachment. , 1992, The Journal of general virology.
[3] S. Nakanishi,et al. Role of the large extracellular domain of metabotropic glutamate receptors in agonist selectivity determination. , 1993, The Journal of biological chemistry.
[4] Terri L. Gilbert,et al. The ligand-binding domain in metabotropic glutamate receptors is related to bacterial periplasmic binding proteins , 1993, Neuron.
[5] B. Conklin,et al. Substitution of three amino acids switches receptor specificity of Gqα to that of Giα , 1993, Nature.
[6] T. Knöpfel,et al. Metabotropic glutamate receptors: novel targets for drug development. , 1995, Journal of medicinal chemistry.
[7] A. Young,et al. Molecular and functional characterization of recombinant human metabotropic glutamate receptor subtype 5 , 1995, Neuropharmacology.
[8] T. Knöpfel,et al. The agonist selectivity of a class III metabotropic glutamate receptor, human mGluR4a, is determined by the N-terminal extracellular domain , 1995, Neuroreport.
[9] J. Bockaert,et al. Molecular, functional, and pharmacological characterization of the metabotropic glutamate receptor type 5 splice variants: comparison with mGluR1 , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[10] Atsuko Fukunaga,et al. A novel class of antagonists for metabotropic glutamate receptors, 7-(Hydroxyimino)cyclopropa[b]chromen-1a-carboxylates , 1996 .
[11] L. Prézeau,et al. Changes in the carboxyl-terminal domain of metabotropic glutamate receptor 1 by alternative splicing generate receptors with differing agonist-independent activity. , 1996, Molecular pharmacology.
[12] J. Neale,et al. N‐Acetylaspartylglutamate Selectively Activates mGluR3 Receptors in Transfected Cells , 1997, Journal of neurochemistry.
[13] J. Baldwin,et al. An alpha-carbon template for the transmembrane helices in the rhodopsin family of G-protein-coupled receptors. , 1997, Journal of molecular biology.
[14] T. Knöpfel,et al. Expression and Coupling to Polyphosphoinositide Hydrolysis of Group I Metabotropic Glutamate Receptors in Early Postnatal and Adult Rat Brain , 1997, The European journal of neuroscience.
[15] J. Pin,et al. Pharmacology and functions of metabotropic glutamate receptors. , 1997, Annual review of pharmacology and toxicology.
[16] L. Prézeau,et al. A Cluster of Basic Residues in the Carboxyl-terminal Tail of the Short Metabotropic Glutamate Receptor 1 Variants Impairs Their Coupling to Phospholipase C* , 1998, The Journal of Biological Chemistry.
[17] J. Bockaert,et al. The G protein-coupling profile of metabotropic glutamate receptors, as determined with exogenous G proteins, is independent of their ligand recognition domain. , 1998, Molecular pharmacology.
[18] J. Bockaert,et al. Comparative effect of l-CCG-I, DCG-IV and γ-carboxy-l-glutamate on all cloned metabotropic glutamate receptor subtypes , 1998, Neuropharmacology.
[19] S. Moro,et al. Human P2Y1 receptor: molecular modeling and site-directed mutagenesis as tools to identify agonist and antagonist recognition sites. , 1998, Journal of medicinal chemistry.
[20] R. Challiss,et al. Reversible and non-competitive antagonist profile of CPCCOEt at the human type 1α metabotropic glutamate receptor , 1998, Neuropharmacology.
[21] S. Nakanishi,et al. Expression and Purification of the Extracellular Ligand Binding Region of Metabotropic Glutamate Receptor Subtype 1* , 1998, The Journal of Biological Chemistry.
[22] F. Gasparini,et al. CPCCOEt, a noncompetitive metabotropic glutamate receptor 1 antagonist, inhibits receptor signaling without affecting glutamate binding. , 1999, Molecular pharmacology.
[23] D. Jane,et al. Pharmacological agents acting at subtypes of metabotropic glutamate receptors , 1999, Neuropharmacology.
[24] Roland Heckendorn,et al. 2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist , 1999, Neuropharmacology.
[25] G. Battaglia,et al. Selective blockade of metabotropic glutamate receptor subtype 5 is neuroprotective , 2000, Neuropharmacology.
[26] B. Meldrum,et al. Anticonvulsant activity of two metabotropic glutamate Group I antagonists selective for the mGlu5 receptor: 2-methyl-6-(phenylethynyl)-pyridine (MPEP), and (E)-6-methyl-2-styryl-pyridine (SIB 1893) , 2000, Neuropharmacology.